Dolphin Medical Services Ltd Stock Price Today (NSE: DOLPHMED)
Fundamental Score
Dolphin Medical Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dolphin Medical Services Ltd share price today is ₹7.14, up +0.00% on NSE/BSE as of 7 August 2026. Dolphin Medical Services Ltd (DOLPHMED) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹12.50 (Cr). The 52-week high for DOLPHMED share price is ₹9.57 and the 52-week low is ₹1.98. At a P/E ratio of 312.50x, DOLPHMED is currently trading above its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 0.40% and a debt-to-equity ratio of 0.09.
Dolphin Medical Services Ltd Share Price Chart — NSE/BSE Historical Performance
Dolphin Medical Services Ltd share price chart: -17.98% return over the past month. 52-week high ₹9.57, 52-week low ₹1.98.
Dolphin Medical Services Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹7.14 | ₹7.14 | ₹7.14 | ₹7.14 | 0.00 (Cr) | |
| ₹7.14 | ₹7.14 | ₹7.14 | ₹7.14 | 0.00 (Cr) | |
| ₹7.85 | ₹7.85 | ₹7.12 | ₹7.14 | 1.23L (Cr) | |
| ₹7.48 | ₹7.48 | ₹7.48 | ₹7.48 | 0.00 (Cr) | |
| ₹7.48 | ₹7.48 | ₹7.48 | ₹7.48 | 0.00 (Cr) | |
| ₹7.48 | ₹7.48 | ₹7.48 | ₹7.48 | 0.00 (Cr) | |
| ₹7.48 | ₹8.26 | ₹7.48 | ₹7.48 | 2.62L (Cr) | |
| ₹7.87 | ₹7.87 | ₹7.87 | ₹7.87 | 0.00 (Cr) | |
| ₹7.87 | ₹7.87 | ₹7.87 | ₹7.87 | 0.00 (Cr) | |
| ₹7.87 | ₹7.87 | ₹7.87 | ₹7.87 | 0.00 (Cr) |
Dolphin Medical Services Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹7.85 | ₹7.85 | ₹7.12 | ₹7.14 | -9.04% | |
| ₹9.12 | ₹9.57 | ₹7.48 | ₹7.48 | -17.98% | |
| ₹7.52 | ₹9.12 | ₹7.52 | ₹9.12 | +21.28% | |
| ₹6.20 | ₹7.17 | ₹6.05 | ₹7.17 | +15.65% | |
| ₹4.88 | ₹5.91 | ₹4.87 | ₹5.91 | +21.11% | |
| ₹3.83 | ₹4.88 | ₹3.64 | ₹4.88 | +27.42% | |
| ₹3.03 | ₹3.83 | ₹3.16 | ₹3.83 | +26.40% | |
| ₹2.93 | ₹3.28 | ₹2.74 | ₹3.17 | +8.19% | |
| ₹2.16 | ₹2.87 | ₹2.16 | ₹2.87 | +32.87% | |
| ₹2.04 | ₹2.27 | ₹1.99 | ₹2.27 | +11.27% | |
| ₹2.16 | ₹2.28 | ₹1.98 | ₹2.05 | -5.09% | |
| ₹2.26 | ₹2.37 | ₹2.01 | ₹2.16 | -4.42% |
AI Research Briefing
Powered by Gemini · 2026-08-01
Brutal shell-takeover play with ₹0.75 Cr annual revenue trading at 312x P/E, strictly for speculative position-flipping around open offer headlines.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Promoters Gude Venkata Mohan Prasad and Lakshmi Sudha Madala executed a Share Purchase Agreement on May 15, 2026, selling a 20.95% stake (31,63,390 shares) to incoming acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar. A mandatory open offer launched on July 31, 2026 (closing August 13, 2026) to acquire up to 26% additional voting capital (39,25,988 shares) from public shareholders at ₹4.80 per share. FY26 full-year sales fell 3.85% YoY to ₹0.75 Cr, though full-year net profit managed ₹0.04 Cr versus a ₹0.03 Cr loss in FY25.
CORE STORY (THE REAL GAME)
This is an operator-driven micro-cap reverse merger and shell-takeover play, not a fundamental healthcare growth story. With top-line revenue under ₹1 Cr annually, investors are betting entirely on incoming promoters injecting new assets or pivoting operations post-takeover.
- Open offer tendering period running from July 31 to August 13, 2026 at ₹4.80 per share
- Promoter control shift to Amarandhar Reddy Kotha and Mallour Rajesh Kumar buying 20.95% stake via SPA
- FY26 full-year results showing sales down 3.85% YoY to ₹0.75 Cr
- Completion of open offer and regulatory reclassification of new promoters
- Post-takeover management announcement of new asset injection or business pivot
- Q1 FY27 earnings showing actual revenue expansion beyond base diagnostic operations
- Illiquid SME micro-cap (₹12.5 Cr market cap) with severe execution and exit risk
- Negligible operating scale with FY26 revenue of just ₹0.75 Cr and negative 5-year FCF of ₹-0.59 Cr
- Absurd 312.5x P/E valuation against an industry average of 42.2x
Zero institutional participation; FII and DII holdings both stand at 0.0% with zero change.
Indian diagnostic and healthcare sector consolidating rapidly, leaving micro-players without scale vulnerable to complete obsolescence.
No major order wins or commercial contracts reported; focus remains solely on the open offer control change.
Poor cash flow quality; 5-year cumulative free cash flow sits at negative ₹-0.59 Cr.
Subdued core execution; performance over 3-6 months depends entirely on incoming promoters injecting fresh capital or new assets.
Primary Thesis Risk
Failure of incoming promoters to inject viable revenue-generating assets into a business generating under ₹1 Cr annually.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dolphin Medical Services Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dolphin Medical Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DOLPHMED across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Robust Profit Growth (114.29%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (35.71%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Excellent EPS Growth (16.32% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (16.32% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.09)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (7.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.40%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.64%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-5.39%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 312.50x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-0.59 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (26.44%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dolphin Medical Services Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Dolphin Medical Services Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dolphin Medical Services LtdDolphin Medical...Selected✓ DOLPHMED • 526504 | 33.4/100 | ₹7.14₹7 | ₹12.50₹12.50 | 312.50Average 312.5 Average | 0.40%Poor 0.40% Poor | 0.64%Poor 0.64% Poor | 0.09Excellent 0.1 Excellent | 16.32%Excellent 16.32% Excellent | 9.80%Good 9.80% Good | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1905.20₹1905 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1344.40₹1344 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹582.45₹582 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹579.00₹579 | ₹8420.27₹8420.27 | 52.36Average 52.4 Average | 28.40%Excellent 28.40% Excellent | 35.38%Excellent 35.38% Excellent | 0.09Excellent 0.1 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹527.45₹527 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹252.15₹252 | ₹1359.30₹1359.30 | 42.23Average 42.2 Average | 14.12%Average 14.12% Average | 16.97%Good 16.97% Good | 0.53Good 0.5 Good | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹564.95₹565 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1248.10₹1248 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹239.10₹239 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Thyrocare Technologies Ltd share price8420.27 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
Dolphin Medical Services Ltd Quarterly Performance
Latest quarterly metrics for DOLPHMED — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
35.71%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
114.29%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.80%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
16.32%
Compounded annual net profit growth over 5 years
Dolphin Medical Services Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for DOLPHMED — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Dolphin Medical Services Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Dolphin Medical Services Ltd (DOLPHMED) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Dolphin Medical Services Ltd
About DOLPHMED (Dolphin Medical Services Ltd)
Dolphin Medical Services Ltd is a prominent healthcare provider committed to delivering comprehensive and advanced medical solutions within the region. With a focus on patient-cent...ric care, DOLPHMED offers a wide spectrum of diagnostic services, including cutting-edge imaging technologies, laboratory testing, and specialized health screenings. We pride ourselves on employing a team of highly qualified and experienced medical professionals who are dedicated to accuracy, efficiency, and personalized attention for every individual. DOLPHMED aims to be a trusted partner in promoting health and well-being within the community by continuously investing in innovative technologies and upholding the highest standards of quality and ethics in the healthcare industry. At Dolphin Medical Services Ltd, we understand the critical role of timely and accurate diagnoses in ensuring positive patient outcomes. Therefore, we are dedicated to providing state-of-the-art diagnostic facilities equipped with the latest medical equipment. Our team of skilled technicians and radiologists work in tandem to deliver precise and detailed results, enabling doctors to make informed decisions about treatment plans. Furthermore, DOLPHMED emphasizes a comfortable and supportive environment for patients undergoing various diagnostic procedures, ensuring their comfort and minimizing anxiety. We are committed to maintaining confidentiality and adhering to strict protocols to safeguard patient information. DOLPHMED is deeply rooted in its commitment to the local community, striving to be a valuable resource for individuals seeking accessible and reliable healthcare services. Through collaborations with local hospitals, clinics, and healthcare professionals, we aim to expand our reach and improve access to essential diagnostic services. We actively participate in health awareness programs and initiatives, promoting preventive care and empowering individuals to take control of their health. Dolphin Medical Services Ltd aspires to be a pillar of support in the community, fostering a healthier and more vibrant society by delivering superior healthcare solutions with compassion and integrity.
Company Details
Key Leadership
DOLPHMED Share Price: Frequently Asked Questions
What is the current share price of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd (DOLPHMED) trades at ₹7.14 on NSE and BSE. Market cap ₹12.50 (Cr). Educational data only.
What is the P/E ratio of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has a P/E of 312.50x vs industry average 42.23x.
What is the Bull Run score for Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has a Bull Run score of 33.4/100 based on 25+ financial parameters.
Does Dolphin Medical Services Ltd pay dividends?
Dolphin Medical Services Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has ROE of 0.40%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has debt-to-equity of 0.09.
Is Dolphin Medical Services Ltd a good investment?
Bull Run gives Dolphin Medical Services Ltd a score of 33.4/100. This is not investment advice — consult a SEBI-registered advisor.